A new trading day began on Monday, with Immunic Inc (NASDAQ: IMUX) stock price up 5.01% from the previous day of trading, before settling in for the closing price of $0.93. IMUX’s price has ranged from $0.56 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 26.01% over the last five years. Meanwhile, its annual earnings per share averaged 30.99%. With a float of $92.55 million, this company’s outstanding shares have now reached $95.82 million.
The firm has a total of 91 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.42%, while institutional ownership is 47.80%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 30.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.24% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Here are Immunic Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Analysing the last 5-days average volume posted by the [Immunic Inc, IMUX], we can find that recorded value of 0.81 million was lower than the volume posted last year of 1.25 million. As of the previous 9 days, the stock’s Stochastic %D was 20.09%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 52.94%, which indicates a significant increase from 41.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0865 in the past 14 days, which was higher than the 0.0795 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8376, while its 200-day Moving Average is $1.0433.
